Who

Worldwide, there have been 777,074,803 confirmed cases of the disease, which is caused by the SARS-CoV-2 virus, and more than seven million deaths.

Tedros called for Abu Safiya's immediate release and said the Al-Ahli hospital had also faced attacks.

The successful containment of the virus highlights Rwanda’s commitment to building resilient health systems and preparing for future public health emergencies.

The reduction has been credited to intensified efforts such as the distribution of insecticide-treated bed nets and the introduction of the RTS, S malaria vaccine, the first of its kind in the world.

The WHO report warns that deprioritising health spending could derail efforts toward achieving universal health coverage (UHC).

The symptoms of the disease, the cause of which has not been established, are fever, headache, cough, runny nose and body aches.

Symptoms of the illness include headache, cough, fever, breathing difficulties and anaemia, according to the WHO.

A medical team has been deployed to the Panzi health zone to collect samples and carry out an analysis to know the root cause of the disease.

The report predicts that these numbers will increase in the coming years due to climate change, which is expected to cause more frequent and severe forest fires.

He had been elected to succeed Matshidiso Moeti as the WHO Regional Director for Africa during the 74th session of the WHO Regional Committee for Africa.

Mpox is a viral infection that spreads through close contact, and typically causes flu-like symptoms and pus-filled lesions. It is usually mild, but it can be lethal.

Reducing sedentary time and incorporating regular movement into daily life are crucial steps towards improving overall health and well-being.

The WHO report reveals that treatment access remains stubbornly low in many developing nations.

Rwanda's Ministry of Health has implemented an enhanced surveillance plan to ensure the detection of any remaining chains of transmission.

WHO said the patients, including children with trauma injuries and chronic diseases, would depart in a large convoy via the Kerem Shalom crossing with Israel.

Kenyan health settings widely use the GeneXpert system, which is the platform for the Xpert Mpox test, a real-time PCR test.

When it comes to TB infections the WHO African and European regions have made the most progress: a reduction of 24% in Africa and 27% in Europe.

Nineteen African countries have seen more than 48,000 suspected mpox cases including 1,048 deaths so far this year, according to the public health agency's data.

According to the World Health Organisation (WHO), over 480 million people in the African region struggle with oral health issues.

Cholera's resurgence extends beyond technical failures; it is deeply intertwined with broader systemic issues such as conflict, climate change, and social inequities.

Risk factors for hypertension include older age, genetics, being overweight, physical inactivity, a high-salt diet, and excessive alcohol consumption.

WHO's latest decision comes after the EU approved the drug for the vaccine for adolescents in September.

Gavi, an international public-private alliance which co-funds vaccine purchases for low-income countries, said on Sept. 18 it would buy 500,000 doses of Bavarian Nordic's vaccine, due to be delivered this year.

The Ministry of Health has intensified surveillance activities to ensure a proactive approach to curbing the virus in the event of any reports.

He said negotiations were ongoing and that a meeting with Israeli authorities about the next phase of the campaign was planned for Sunday.

Africa CDC Director General Jean Kaseya said that several hundred high-risk individuals in Rwanda received the vaccine earlier this week.

The absence of capnography in many low-resource settings is primarily due to their high cost and the scarcity of devices tailored to local needs.

These include severe limb injuries, amputations, spinal cord trauma, traumatic brain injuries and major burns.

The first two cases in Uganda were confirmed in July.

The vaccine, known as MVA-BN, is administered in two doses, four weeks apart, to individuals over 18 years.